Ibrahima Diouf

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

A. Fontbonne, M. Charles, E. Eschwège, 2009, Diabetes & metabolism.